Cortexyme Inc
Change company Symbol lookup
Select an option...
CRTX Cortexyme Inc
NVEC NVE Corp
PFE Pfizer Inc
SCBH Seacoast Commerce Banc Holdings
PHX Panhandle Oil and Gas Inc
BTU Peabody Energy Corp
CLNY Colony Capital Inc
BAC Bank of America Corp
USAK USA Truck Inc
BABA Alibaba Group Holding Ltd
Go

Company profile

Cortexyme, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on providing disease-modifying therapeutics to treat Alzheimer’s and other degenerative diseases. The Company is focused on a infectious pathogen tied to neurodegeneration in humans and animal models. The Company’s lead drug candidate, COR388, is an orally-administered, brain-penetrating small molecule gingipain inhibitor designed for the treatment of Alzheimer’s disease. COR388 is designed to target an upstream driver of multiple Alzheimer’s pathological pathways, including amyloid beta production, inflammation and neurodegeneration, in contrast to mechanisms of action targeting downstream effects, such as amyloid plaques and tau tangles.

Closing Price
$58.32
Day's Change
-0.32 (-0.55%)
Bid
--
Ask
--
B/A Size
--
Day's High
61.86
Day's Low
57.00
Volume
(Light)
Volume:
128,991

10-day average volume:
192,305
128,991
  • Prev Close
    58.64
  • Today's Open
    58.50
  • Day's Range
    57.00-61.86
  • Avg Vol (10-day)
    192.3K
  • Last (time)
    4:00p ET 01/21/20
  • Last (size)
    7
  • 52-Wk Range
    19.35 - 72.94
    LowHigh
  • (08/30/19 - 12/23/19)
    20.04%
  • 107.3%
  • Market Cap
    1.6B
  • Shares Outstanding
    26.9M
  • --
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 31.37
  • (% of float 12/31/19)
    11.82

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.